Gastrointestinal side effects and conflicting systemic risks were noted across procedures.<h4>Conclusion</h4>Current observational data suggest that perioperative GLP-1 RA use in patients undergoing total hip or knee arthroplasty is not associated with a consistent increase in short-term revision rates and may be associated with a reduced risk of postoperative infection. Here, GLP1R is linked to infection.